Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    18 March 2024

    Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies

    Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services Immunome signs deal to use Arrayjet platform in its in-house screening operations Edinburgh, Scotland, 18 March 2024: Arrayjet, a leadin...

    19 March 2024

    EFEC in Lingang, Shanghai helping to develop next stages of the Lingang Cambridge Network

    In 2019, EFEC worked with Cambridge Network and the Shanghai Lingang Construction and Investment Company to set up the Lingang Cambridge Network, in Lingang, Shanghai. The pandemic then intervened, but EFEC is now back working with the LCN to develop the network and the basis for enhan...

    18 March 2024

    Realising the potential of digital biomarkers in respiratory care

    As healthcare progresses into the digital age, digital biomarkers offer tremendous potential for transforming and improving outcomes in respiratory care, particularly for conditions such as COPD and asthma [1]. The term “digital biomarker” refers to objective and quantifiable physiologi...

    18 March 2024

    D-CYPHRing DNA and the power of spit - BioResource at the Cambridge Festival

    Most diseases start in childhood, but most health research is carried out in adults. As a result, a big gap exists in our fundamental understanding of how health conditions begin and evolve. An ambitious programme from the NIHR BioResource – the DNA, Children + Young People’s Health Re...

    15 March 2024

    World’s first IVF clinic Bourn Hall partners with national charity Fertility Network UK to help more employers implement ‘fertility fairness’ in their workplace

    The world’s first IVF clinic, Bourn Hall, is joining forces with the UK’s national fertility charity, Fertility Network UK, on their Fertility in the Workplace (FiTW) initiative, which helps firms support staff experiencing fertility struggles. ...

    14 March 2024

    Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

    Key appointment to lead global commercial launch of eProtein Discovery platform

    13 March 2024

    Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement

    CRISPR/Cas9 genome editing technology contributes to the expansion of the creation of novel disease model ...

    13 March 2024

    New Cambridge CF firm advises on sale of Cambridge based Cogentia Healthcare Consulting to Helios Global Group

    Alfa Corporate Finance advises on sale of HEOR and market access specialist Cogentia Healthcare Consulting to Helios Global Group ...

    13 March 2024

    Addenbrooke’s Charity supporters have raised over £100,000 for the new Cambridge Cancer Research Hospital in just one weekend

    Earlier this month, Addenbrooke’s Charitable Trust’s (ACT) amazing supporters pulled out all the stops with three magnificent fundraising events raising more than £100,000 for the new Cambridge Cancer Research Hospital. The funds raised will help to change the story of cancer, bringing ...

    13 March 2024

    Shining a light on the future of business: The Guildhall to light up for B Corp Month this March

    Between 13 and 20 March, The Guildhall, in Cambridge City’s Market Square, will light up in white, yellow and pink to celebrate B Corp Month, which takes place throughout March. The visual celebration by Cambridge City Council is in recognition of the growing number of B Corp certified ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 152
    • Page 153
    • Current page 154
    • Page 155
    • Page 156
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS